ArticlePDF AvailableLiterature Review

Circadian Rhythm and the Skin: A Review of the Literature

Authors:
  • Forefront Dermatology

Abstract

Disruption of the circadian rhythm has been implicated in a wide variety of dermatologic conditions. Research has shown that previous ultraviolet light exposure can continue to damage the deoxyribonucleic acid (DNA) of the skin, even in the dark, and has demonstrated that repair of these skin cells peaks at night. In this article, the authors reviewed the current literature on circadian rhythm effects on the skin and describe and discuss its basic principles. Better understanding of the role circadian rhythm plays in overall skin health will assist physicians in providing optimal treatment to patients, including appropriate recommendations regarding the use of topical medications and skin care at their most effective times during a 24-hour cycle. Dermatologists should also be aware that adequate sleep is necessary for optimal DNA repair activity in the skin.
42
JCAD JOURNAL OF CLINICAL AND AESTHETIC DERMATOLOGY September 2019 • Volume 12 • Number 9
REVIEW
T
The term circadian rhythm refers to the body’s
endogenous 24-hour physiologic, metabolic,
and behavioral rhythms.1 The circadian rhythm
is controlled by the central regulator, or master
clock, which is located in the suprachiasmatic
nucleus (SCN) of the anterior hypothalamus
and is greatly in uenced by light and the
environment.1,2 The clock mechanisms function
by transcription and translation feedback loops
of circadian clock genes and their proteins.3
Peripheral organs, such as the skin, also
contribute to the circadian rhythm and possess
endogenous rhythmicity.2
The pineal gland secretes melatonin, which is
considered to be a major regulator of circadian
homeostasis.4 Melatonin levels  uctuate with the
circadian rhythm and are typically high at night
and low during the day.5 Exposure to light leads to
an acute drop in melatonin levels and a decrease
in melatonin production secondary to feedback
inhibition.6 Melatonin has been associated
with hair growth, suppression of ultraviolet
(UV) damage in skin cells, wound healing, and
antitumor e ec ts.4,5,7 Oral melatonin supplements
are commonly used to promote sleep, and studies
have shown melatonin can advance the onset
of nocturnal melatonin secretion.8,9 Because it
has antioxidant e ects, topical melatonin has
been used in wound healing, sun protection, and
antiaging products with varying results.10–14
Circadian rhythm disruption has been studied
in detail and is thought to contribute to the risk of
cancer and other diseases, as well as have various
e ects on the skin, ranging from transepidermal
water loss to keratinocyte proliferation.15 Studies
have also shown that repair of DNA-damaged skin
cells, as a result of UV exposure, peaks at night.16
Additionally, previous exposure to UV light can
continue to damage skin DNA, even in the dark.17
By understanding the basic principles of
the circadian rhythm, including skin changes
throughout the day, physicians might
better target therapy for their patients by
recommending use of topical medications and
skin care products at optimal times of the day,
(e.g., sunscreen during the day, DNA repair
enzyme cream at night). Dermatologists should
also be aware that adequate sleep is necessary
for optimal DNA repair activity in the skin. In this
article, we review the current literature regarding
circadian rhythm and its e ects on overall skin
health as well as implications that time of day can
impact the e ectiveness of topical medications
and skin care products.
CIRCADIAN RHYTHM AND THE SKIN
In addition to the SCN, the circadian system
is also composed of peripheral circadian
oscillators in many other cells, including the
skin.18 The skin contains circadian clock genes,
ABSTRACT
Disruption of the circadian rhythm has been
implicated in a wide variety of dermatologic
conditions. Research has shown that previous
ultraviolet light exposure can continue to damage
the deoxyribonucleic acid (DNA) of the skin, even
in the dark, and has demonstrated that repair of
these skin cells peaks at night. In this article, the
authors reviewed the current literature on circadian
rhythm e ects on the skin and describe and discuss
its basic principles. Better understanding of the role
circadian rhythm plays in overall skin health will
assist physicians in providing optimal treatment to
patients, including appropriate recommendations
regarding the use of topical medications and skin
care at their most e ective times during a 24-hour
cycle. Dermatologists should also be aware that
adequate sleep is necessary for optimal DNA repair
activity in the skin.
KEYWORDS: Circadian rhythm, DNA repair,
melatonin
Circadian Rhythm and
the Skin: A Review of the
Literature
by ALEXIS B. LYONS, MD; LAUREN MOY, MD; RONALD MOY, MD;
and REBECCA TUNG, MD
Dr. Lyons is with the Department of Dermatology at Henry Ford Hospital in Detroit, Michigan. Drs. L. Moy and Tung are with
the Department of Dermatology at Loyola University Medical Center in Chicago, Illinois. Dr. R. Moy is with Moy, Fincher, Chipps
Facial Plastics and Dermatology in Beverly Hills, California.
J Clin Aesthet Dermatol. 2019;12(9):42–45
FUNDING: No funding was provided for this study.
DISCLOSURES: The authors have no con icts of interest relevant to the content of this article.
CORRESPONDENCE: Alexis Lyons, MD; Email: alexisblyons@gmail.com
43
JCAD JOURNAL OF CLINICAL AND AESTHETIC DERMATOLOGY September 2019 • Volume 12 • Number 9
REVIEW
which play a role in the regulation of the
circadian rhythm.18 Transepidermal water loss,
keratinocyte proliferation, skin blood  ow, and
skin temperature have all been shown to have
circadian variations.
The stratum corneum undergoes circadian
rhythm changes, with skin permeability being
higher in the evening than in the morning.16
Aquaporin 3 (AQP3) is expressed in the epidermis
and is regulated by molecular clocks, which
contribute to transepidermal water loss.15 Because
transepidermal water loss is associated with
increased pruritus in cases of atopic dermatitis,
this increase in water loss from the skin in the
evening coincides increased itchiness at night.19
These factors of increased in ammation and
skin permeability at night could be important
clinically. Thus, moisturizers and topical steroids
might o er increased bene ts when used in the
evening hours.
The e ect that topical medications have on
the skin also varies throughout the day. Skin
penetration of hydrophilic and lipophilic topical
medications is at its maximum at around 04:00
hours (4:00am), with absorption slowing
throughout the daylight hours.20 The penetration
of topical lidocaine is also greater at night.21 This
is likely due to the increase in skin permeability at
night, as discussed above.
Another component that may a ect the
e cacy of topical medications and absorption is
the rate of blood  ow in the skin. The skin blood
ow rate has also been shown to be a ected
by the circadian rhythm, increasing in the late
afternoon and at night.22 A study by Yosipovitch
et al16 demonstrated that these circadian
rhythm blood  ow rates were maintained even
during treatment with topical corticosteroids.
Vasodilation and increased skin blood  ow have
been shown to accelerate drug passage through
the skin and di usion through the tissues into the
systemic circulation.23
Proliferation of keratinocytes has also been
found to vary during the day, with the highest
rate of proliferation occurring around midnight.24
Cancerous skin cells have been shown to lose
their rhythmicity, while healthy cells appear to
peak around midnight and trough at midday.25
Sebaceous gland activity also varies throughout
the day, with minimal activity around 04:00 hours
and maximum activity at midday.16 This variation
is not thought to be linked to variations in skin
temperature or hormone production, but the
cause of the rhythmicity is unknown.26
Human hair follicles have been shown to
experience circadian changes and express the
core clock genes CLOCK, BMAL1, and Period1,
which modulate the hair follicle cycle even in
the absence of input from the SCN.27 A study
by Al-Nuaimi et al27 suggested that these clock
genes could be potential therapeutic targets for
stimulating hair growth. In a study by Hardman
et al,28 researchers found that hair follicle
melanin content was increased by silencing
BMAL1 and PER1, suggesting that the circadian
clock genes play a role in pigmentation.
Targeting these genes could potentially aid in
treatment of hair pigmentation disorders.
Cortisol levels also  uctuate throughout
the day. There is a natural trough in cortisol
levels during the evening, which could
be a contributing factor in patients with
in ammatory skin conditions who have
increased pruritus at night.6 Approximately
65 percent of patients with in ammatory
dermatoses, including atopic dermatitis and
psoriasis, have increased pruritus at night.7
The circadian rhythm also controls the core
body temperature and skin temperature.16,29
The core body temperature has predictable
uctuations with higher temperatures in the
daylight hours than during the night hours, with
a trough in the early morning,6 whereas skin
temperature peaks in the afternoon and has
a trough at night.16 Relating to this, psoriasis
has been associated with problems related
to thermoregulation , which might lead to
di culty falling asleep and disruption of the
circadian rhythm.30
Psoriasis has also been linked to circadian
rhythm abnormalities, although the
pathophysiology is still unclear. A study by
Mozzanica31 found that patients with psoriasis
had reduced levels of melatonin. Another study
showed an increased incidence of psoriasis
in night-shift workers.32 Additionally, the
CLOCK gene has been linked to the regulation
of psoriasis by regulating interleukin-23R
expression in mice.33 Further studies are needed
to elucidate the relation of the circadian clock
with psoriasis.
CIRCADIAN RHYTHM AND CANCER
Numerous studies have shown that
alterations in sleep/wake cycles that interfered
with the circadian rhythm resulted in an
increased cancer risk. Nurses who work the
night shift have been shown to have an
increased risk of breast cancer compared to
those who work the day shift.5,34 The incidence
of breast cancer has also been shown to
be higher in female  ight attendants, who
frequently cross time zones and experience
disruptions in their circadian rhythm.35
In breast and endometrial cancer, the
expression of the circadian period gene,
Per2, is inhibited, possibly leading to tumor
development.1 This disruption in circadian
rhythm suggests that shift workers have lower
levels of melatonin. Sleep deprivation leads
to melatonin suppression and subsequent
immunode ciency via the suppression of
natural killer-cell activity and changes in
T-helper cell cytokine balance.36–38
The circadian rhythm in rodent models
has also been studied. As mentioned above,
the pineal gland secretes melatonin, which
regulates the circadian rhythm.39 Rodents
in which the pineal gland was removed
experienced an increased number of tumors.40
Exposure to light during non-daylight hours
in mice resulted in inactivation of Per2, which
promoted tumor development.41
In contrast with other malignancies, the
risk of skin cancer in night-shift workers
has been shown to be reduced compared
to individuals who worked during the day.
In a study by Schernhammer et al,42 there
was an overall 14-percent decreased risk for
skin cancer and 44-percent decreased risk
for melanoma among night-shift workers.
These  ndings are in contrast with the
ndings of studies that showed an association
between lower levels of melatonin and
an increased risk of other cancers among
night-shift workers.5,34,35 Schernhammer et
al41attributes these lower rates of skin cancer
ndings to the protection against melanoma
and nonmelanoma skin cancers that lower
melatonin levels might o er.42 Despite this, a
true cause-and-e ect relationship between
melatonin and the development of melanoma
is not well-established. While causality is not
established, perhaps getting a good night’s
sleep following exposure to the sun is not
su cient for repair to occur using the body’s
own defenses. Another theory for this lower
rate of skin cancer is that the night-shift
workers presumably have less sun exposure,
since they are typically sleeping during the
day and are awake at night. Nevertheless,
additional studies examinining incidence of skin
44
JCAD JOURNAL OF CLINICAL AND AESTHETIC DERMATOLOGY September 2019 • Volume 12 • Number 9
REVIEW
cancer in shift workers have found no signi cant
di erences when compared with to the general
population.43,44
CIRCADIAN RHYTHM,
IMMUNODEFICIENCY, AND DNA REPAIR
The repair of skin cells with DNA damage
from the sun appears to peaks at night.16 A
recent study by Manzella et al45 found that
oxidative damage followed a circadian rhythm,
where the DNA damage was less in the morning
hours than later on in the day. This variation
was thought to be due to 8-oxoguanine DNA
glycosylase (OGG1), which acts to repair
8-Oxoguanine (8-oxoG) DNA damage via the
DNA base excision repair pathway.45 OOG1 DNA
repair activity was higher in the morning and,
thus, 8-oxoG DNA damage levels were lower
in the morning.45 This same study found that
night-shift workers had decreased levels of
OGG1 DNA repair expression compared to the
control group.45 This suggests that during the
early morning hours, the body best performs
DNA repair and that optimal DNA repair occurs
with optimal sleep.
A study by Premi et al17 found that sun
exposure continued to damage skin DNA for
up to three hours following exposure via a
chemical process called the “dark pathway.
These investigators found that direct exposure
to UV light caused DNA damage in all skin
cells, but only the melanocytes accumulated
DNA damage in the absence of light. Premi et
al17 also proposed that α-tocopherol (vitamin
E) and ethyl sorbate could stop DNA damage
from occurring after UV exposure.Studies
have also shown that vitamin D exhibits anti-
in ammatory e ects after UV exposure and
reduces sunburn, thymidine dimer formation,
and photocarcinogenesis.46–48 A recent
combination supplement containing vitamin D
resulted in an increased minimal erythema dose
in patients, thus providing photoprotection and
reducing sunburn risk.49 These studies suggest
that daytime sun protection with sunscreens
and nighttime application with topical DNA
repair enzyme creams might be the optimal
regimen for preventing skin cancer.
CONCLUSION
The important role that circadian rhythm
plays in skin health is a fundamental concept
and is regulated by the SCN and peripheral
oscillators. Physicians should be aware of
variations in skin function and characteristics
throughout the day to better understand
patient symptoms and to maximize
therapeutic bene t. By understanding the
basic principles of the circadian rhythm
including skin changes that occur throughout
the day, physicians can better target therapy
for their patients by recommending the use of
topical medications and skin care products at
optimal times of the day, including sunscreens
during the day and DNA repair enzyme creams
at night. Dermatologists should also be aware
that adequate sleep is necessary for optimal
DNA repair activity to occur in the skin.
REFERENCES
1. Chen ST, Choo KB, Hou MF, Yeh KT, Kuo SJ, Chang
JG. Deregulated expression of the PER1, PER2
and PER3 genes in breast cancers. Carcinogenesis.
2005;26(7):1241–1246.
2. Tanioka M, Yamada H, Doi M, et al. Molecular
clocks in mouse skin. J Invest Dermatol.
2009;129(5):1225–1231.
3. Ukai H, Ueda HR. Systems biology of mammalian
circadian clocks. Annu Rev Physiol. 2010;72:579–
603.
4. Kleszczynski K, Hardkop LH, Fischer TW.
Di erential e ects of melatonin as a broad range
UV-damage preventive dermato-endocrine
regulator. Dermatoendocrinol. 2011;3(1):27–31.
5. Schernhammer ES, Laden F, Speizer FE, et al.
Rotating night shifts and risk of breast cancer in
women participating in the nurses’ health study.
J Natl Cancer Inst. 2001;93(20):1563–1568.
6. Gupta MA, Gupta AK. Sleep-wake disorders and
dermatology. Clin Dermatol. 2013;31(1):118–
126.
7. Ozler M, Simsek K, Ozkan C, et al. Comparison
of the e ect of topical and systemic melatonin
administration on delayed wound healing in rats
that underwent pinealectomy. Scand J Clin Lab
Invest. 2010;70(6):447–452.
8. Lewy AJ, Ahmed S, Jackson JM, Sack RL.
Melatonin shifts human circadian rhythms
according to a phase-response curve. Chronobiol
Int. 1992;9(5):380–392.
9. Deacon S, Arendt J. Melatonin-induced
temperature suppression and its acute phase-
shifting e ects correlate in a dose-dependent
manner in humans. Brain Res. 1995;688
(1–2):77–85.
10. Dreher F, G abard B, Schwindt DA, Maibach HI.
Topical melatonin in combination with vitamins
E and C protects skin from ultraviolet-induced
erythema: a human study in vivo. Br J Dermatol.
1998;139(2):332–339.
11. Scheuer C, Pommergaard HC, Rosenberg J,
Gogenur I. Dose dependent sun protective e ect
of topical melatonin: A randomized, placebo-
controlled, double-blind study. J Dermatol Sci.
2016;84(2):178–185.
12. ŞEner A, ÇEvİK Ö, DoĞAn Ö, et al. The e ects
of topical melatonin on oxidative stress,
apoptosis signals, and p53 protein expression
during cutaneous wound healing. Turk J Biol.
2015;39(6):888Turkish Journal of Biology. 895.
13. Ozler M, Simsek K, Ozkan C, et al. Comparison
of the e ect of topical and systemic melatonin
administration on delayed wound healing in rats
that underwent pinealectomy. Scand J Clin Lab
Invest. 2010;70(6):447–452.
14. Day D, Burgess CM, Kircik LH. Assessing the
potential role for topical melatonin in an
antiaging skin regimen. J Drugs Dermatol.
2018;17(9):966–969.
15. Matsunaga N, Itcho K, Hamamura K, et al.
24-hour rhythm of aquaporin-3 function in the
epidermis is regulated by molecular clocks. J
Invest Dermatol. 2014;134(6):1636–1644.
16. Yosipovitch G, Xiong GL, Haus E, et al. Time-
dependent variations of the skin barrier function
in humans: transepidermal water loss, stratum
corneum hydration, skin surface pH, and skin
temperature. J Invest Dermatol. 1998;110(1):20–
23.
17. Premi S, Wallisch S, Mano CM, et al.
Photochemistry. Chemiexcitation of melanin
derivatives induces DNA photoproducts long
after UV exposure. Science. 2015;347(6224):842–
847.
18. Zanello SB, Jackson DM, Holick MF. Expression
of the circadian clock genes clock and period1 in
human skin. J Invest Dermatol. 2000;115(4):
757–760.
19. Patel T, Ishiuji Y, Yosipovitch G. Nocturnal itch:
why do we itch at night?. Acta Derm Venereol.
2007;87(4):295–298.
20. Reinberg AE, Soudant E, Koulbanis C, et al.
Circadian dosing time dependency in the
forearm skin penetration of methyl and hexyl
nicotinate. Life Sci. 1995;57(16):1507–1513.
21. Bruguerolle B, Giaufre E, Prat M. Temporal
variations in transcutaneous passage of drugs:
the example of lidocaine in children and in rats.
Chronobiol Int. 1991;8(4):277–282.
22. Smolander J, Harma M, Lindqvist A, et al.
Circadian variation in peripheral blood  ow in
relation to core temperature at rest. Eur J Appl
45
JCAD JOURNAL OF CLINICAL AND AESTHETIC DERMATOLOGY September 2019 • Volume 12 • Number 9
REVIEW
Physiol Occup Physiol. 1993;67(2):192–196.
23 Lemmer B, Bruguerolle B.
Chronopharmacokinetics. Are they clinically
relevant?. Clin Pharmacokinet. 1994;26(6):
419–427.
24. Frentz G, Moller U, Holmich P, Christensen IJ.
On circadian rhythms in human epidermal
cell proliferation. Acta Derm Venereol.
1991;71(1):85–87.
25. Zagula-Mally Z, Cardoso SS, Williams D, et al.
Time point di erences in skin mitotic activity of
actinic keratosis and skin cancers. In: Reinberg
A, HF, ed. Chronopharmacology. New York:
Pergamon Press; 1979:399–402.
26. Le Fur I, Reinberg A, Lopez S, et al. Analysis of
circadian and ultradian rhythms of skin surface
properties of face and forearm of healthy
women. J Invest Dermatol. 2001;117(3):
718–724.
27. Al-Nuaimi Y, Hardman JA, Biro T, et al. A meeting
of two chronobiological systems: circadian
proteins Period1 and BMAL1 modulate the
human hair cycle clock. J Invest Dermatol.
2014;134(3):610–619.
28. Hardman JA, Tobin DJ, Haslam IS, et al. The
peripheral clock regulates human pigmentation.
J Invest Dermatol. 2015;135(4):1053–1064.
29. Rogers NL FS. Thermoregulation and sleep-wake
behavior in humans. In: Amlaner CJ, Fuller PM,
ed. Basics of Sleep Guide. 2nd ed. Westchester IL:
Sleep Research Society; 2009:179–186.
30. Leibowitz E, Seidman DS, Laor A, et al. Are
psoriatic patients at risk of heat intolerance? Br J
Dermatol. 1991;124(5):439–442.
31. Mozzanica N, Tadini G, R adaelli A, et al. Plasma
melatonin levels in psoriasis. Acta Derm Venereol.
1988;68(4):312-316.
32. Li WQ, Qureshi AA, Schernhammer ES, Han J.
Rotating night-shift work and risk of psoriasis in
US women. J Invest Dermatol. 2013;133(2):
565–567.
33. Ando N, Nakamura Y, Aoki R, et al. Circadian gene
clock regulates psoriasis-like skin in ammation
in mice. J Invest Dermatol. 2015;135(12):3001–
3008.
34. Schernhammer ES, Kroenke CH, Laden F,
Hankinson SE. Night work and risk of breast
cancer. Epidemiology. 2006;17(1):108–111.
35. Megdal SP, Kroenke CH, Laden F, Pukkala E,
Schernhammer ES. Night work and breast cancer
risk: a systematic review and meta-analysis. Eur J
Cancer. 2005;41(13):2023–2032.
36. Everson CA. Sustained sleep deprivation impairs
host defense. Am J Physiol. 1993;265(5 Pt
2):R1148–1154.
37. Irwin M, McClintick J, Costlow C, et al. Partial
night sleep deprivation reduces natural killer and
cellular immune responses in humans. FASEB J.
1996;10(5):643–653.
38. Dimitrov S, Lange T, Tieken S, et al. Sleep
associated regulation of T helper 1/T helper 2
cytokine balance in humans. Brain Behav Immun.
2004;18(4):341–348.
39. Lerner AB, Case JD, Takahashi Y, Lee TH, Mori W.
Isolation of melatonin, the pineal gland factor
that lightens melanocytes. J Am Chem Soc.
1958;80(10):2587–2587.
40. Anisimov VN, Baturin DA, Popovich IG, et al.
E ect of exposure to light-at-night on life span
and spontaneous carcinogenesis in female CBA
mice. Int J Cancer. 2004;111(4):475–479.
41. Fu L, Pelicano H, Liu J, Huang P, Lee C. The
circadian gene Period2 plays an important role in
tumor suppression and DNA damage response in
vivo. Cell. 2002;111(1):41–50.
42. Schernhammer ES, Razavi P, Li TY, Qureshi AA,
Han J. Rotating night shifts and risk of skin
cancer in the nurses’ health study. J Natl Cancer
Inst. 2011;103(7):602–606.
43. Schwartzbaum J, Ahlbom A, Feychting M. Cohort
study of cancer risk among male and female
shift workers. Scand J Work Environ Health.
2007;33(5):336–343.
44. Parent ME, El-Zein M, Rousseau MC, Pintos J,
Siemiatycki J. Night work and the risk of cancer
among men. Am J Epidemiol. 2012;176(9):
751–759.
45. Manzella N, Bracci M, Strafella E, et al. Circadian
modulation of 8-oxoguanine DNA damage
repair. Sci Rep. 2015;5:13752.
46. Song EJ, Gordon-Thomson C, Cole L, et al.
1alpha,25-Dihydroxyvitamin D3 reduces
several types of UV-induced DNA damage and
contributes to photoprotection. J Steroid Biochem
Mol Biol. 2013;136:131–138.
47. Gordon-Thomson C, Gupta R, Tongkao-on W, et
al. 1alpha,25 dihydroxyvitamin D3 enhances
cellular defences against UV-induced oxidative
and other forms of DNA damage in skin.
Photochem Photobiol Sci. 2012;11(12):
1837–1847.
48. Dixon KM, Norman AW, Sequeira VB, et al.
1alpha,25(OH)(2)-vitamin D and a nongenomic
vitamin D analogue inhibit ultraviolet radiation-
induced skin carcinogenesis. Cancer Prev Res
(Phila). 2011;4(9):1485–1494.
49. Morse NL, Reid AJ, St-Onge M. An open-label
clinical trial assessing the e cacy and safety
of Bend Skincare Anti-Aging Formula on
minimal erythema dose in skin. Photodermatol
Photoimmunol Photomed. 2018;34(2):152–161.
JCAD
... Keduanya terkoordinasi untuk menghasilkan ritme harian dalam fisiologi dan perilaku. 1,2,3 Informasi tentang siklus terang-gelap yang merupakan sinkronisasi utama dari SCN diterima oleh fotoreseptor mata dan mencapai SCN melalui saluran retinohypothalamic (RHT). 4,5 Melatonin adalah hormon yang diproduksi oleh kelenjar pineal pada malam hari dan diyakini sebagai pembawa pesan waktu yang memberikan seluruh tubuh informasi tentang waktu dan musim (fotoperiode). ...
... 4,5 Melatonin adalah hormon yang diproduksi oleh kelenjar pineal pada malam hari dan diyakini sebagai pembawa pesan waktu yang memberikan seluruh tubuh informasi tentang waktu dan musim (fotoperiode). 3,4 Diferensiasi keratinosit terutama terjadi pada malam dan dini hari, sehingga proses perbaikan pertahanan kulit dimulai pada pagi hari. Akibatnya, fungsi sawar kulit mencapai kinerja optimal pada siang hari dibandingkan malam hari. ...
... Stratum korneum mengalami perubahan ritme sirkadian, dengan permeabilitas kulit yang lebih tinggi pada malam hari dibandingkan pada pagi hari (Gambar 4). 3,4 Gambar 3. Pengaturan ritme sirkadian pada kulit 2 ...
Article
Full-text available
Irama sirkadian mengacu pada ritme fisiologis, metabolisme dan perilaku 24 jam endogen tubuh. Ritme sirkadian dikendalikan oleh pengatur pusat atau jam utama yang terletak di nukleus suprakiasmatik hipotalamus anterior dan sangat dipengaruhi oleh cahaya dan lingkungan. Sinkronisasi jam biologis irama sirkadian pada tubuh disebut sebagai osilasi. Irama sirkadian memperlihatkan hubungan fase tertentu dengan siklus terang-gelap atau aktivitas-istirahat melalui sinyal neurohumoral, contohnya adalah melatonin yang membawa pesan waktu pada seluruh tubuh mengenai informasi tentang waktu dan musim (fotoperiode). Kulit terdiri atas tiga lapisan yaitu epidermis, dermis, dan hipodermis dimana ketiganya berperan penting dalam mempertahankan keseimbangan atau homeostasis yang diatur oleh ritme sirkadian Ritme sirkadian pada kulit memiliki fungsi dalam pengaturan proliferasi berbagai jenis sel, yaitu: keratinosit, fibroblas, melanosit, kelenjar sebasea, dan folikel rambut. Sinar Ultraviolet (UV) dapat menyebabkan pembentukan Reactive Oxygen Species (ROS) yang berlebihan yang secara langsung dapat menyebabkan stres oksidatif dalam sel. Penuaan dikaitkan dengan perubahan dalam irama sirkadian dan peningkatan akumulasi ROS. Perawatan kulit (skin care) berdasarkan ritme sirkadian merupakan hal yang penting untuk diketahui. Pemahaman mengenai irama sirkadian pada kesehatan kulit sangat bermanfaat dalam menjaga kondisi kulit agar tetap sehat.
... Sleep modulates the entire organism, encompassing hormonal, neuroendocrine, immune and metabolic regulation that can all have significant effects on the skin [3,5,8,12]. The skin has its own peripherical circadian clock, and the main cell groups of the skin -keratinocytes, fibroblasts, and melanocytes, are regulated by circadian rhythm [3,5,8]. ...
... Sleep modulates the entire organism, encompassing hormonal, neuroendocrine, immune and metabolic regulation that can all have significant effects on the skin [3,5,8,12]. The skin has its own peripherical circadian clock, and the main cell groups of the skin -keratinocytes, fibroblasts, and melanocytes, are regulated by circadian rhythm [3,5,8]. They act in the epidermal barrier, and are associated with immune local defense. ...
... Increased levels of the cytokine IL-17 A have already been shown to be related to lower levels of vitamin D in vitiligo activity [41], which calls attention to a possible reverse relationship between vitamin D and proinflammatory cytokines in vitiligo. Sleep distress may affect immune regulation [3,5]; triggering hormonal and autoimmune alterations that can increase skin flare-up. The supplementation of vitamin D should be considered as an adjuvant strategy option to the clinical management of autoimmune diseases [42], including vitiligo. ...
Article
Full-text available
Vitiligo is an autoimmune skin disease that can be influenced by stress, including that resulting from sleep deprivation and sleep disturbances. Sleep is essential in the regulation of several hormonal, metabolic and autoimmune pathways that may have important roles in vitiligo. This study aimed to investigate the potential interplay between hormonal, metabolic, and autoimmune markers in vitiligo patients, and the possible influence of sleep quality in these vitiligo pathways. A cohort of 30 vitiligo patients and 26 healthy controls were assessed for various laboratory markers, including thyroid-stimulating hormone (TSH), parathyroid hormone (PTH), serum calcium, 1.25(OH)2D, 25(OH)D, anti-thyroid peroxidase (anti-TPO), anti-thyroglobulin (anti-TG), and antinuclear antibodies (ANA). The study evaluated sleep quality using the Pittsburgh Sleep Quality Index (PSQI). Positive anti-TPO were found in the vitiligo group, but did not in the control group. Vitamin D 25(OH)D mean levels were clinically insufficient in both groups (< 30 mg/dL). Reactive ANA was analyzed with 2 variables related to vitiligo: phototherapy and skin activity. No statistical correlation was found in the chi-square test on this relationship. Descriptive findings have shown that the positivity to anti-TPO and anti-TG, associated or not with reactive ANA, was higher in vitiligo group. Great part (85.7%) of vitiligo group were “poor sleepers” (PSQI > 5), which has increased (88.2%) when considering only individuals with signs of vitiligo activity. Autoimmune hypothyroidism and positive anti-TPO are expected in vitiligo, although this marker is not usually measured in the first laboratory screening to this disease. Adequate vitamin D levels may be a key adjuvant in skin pigmentation, and be related to sleep quality and immune regulation, as this vitamin can be related to better sleep and immunomodulation in autoimmune diseases. Evaluating ANA before phototherapy can be controversial, but it should be considered in cases with a poor response to this treatment, or when there is a higher risk of other autoimmune diseases. Poor sleep predominated in the vitiligo group, based on PSQI scores that reported worse subjective sleep in these patients. Worse sleep predominated in individuals with signs of skin activity and reactive autoimmune markers. Screening these components could be important in the management of vitiligo, as maintaining body homeostasis can help to improve the disease course. Sleep should be considered as a potential modulator of several multidirectional vitiligo pathways.
... Skin cells, including keratinocytes, possess an autonomous circadian clock that is essential for maintaining skin homeostasis and function 3,4 . Processes such as epidermal moisture loss, corneal cell proliferation, skin blood flow, and skin temperature regulation each undergo circadian changes 5,6 . Antioxidant production and repair enzyme activity are generally higher during the day; this helps to prevent the damaging effects of ultraviolet radiation and environmental pollutants 7,8 . ...
Article
Full-text available
Circadian rhythms, intrinsic 24-h cycles regulating physiological processes, are crucial for skin homeostasis. Disruptions in these rhythms are linked to various skin disorders and impaired barrier function. Circadian rhythms can be modulated by botanical compounds, which hold therapeutic potential. However, the effect of cinnamomi cortex (CC), an anti-inflammatory, antioxidant, and antimicrobial agent, on the circadian rhythm of keratinocytes remains unclear. This study aimed to examine the effects of CC extract and its 18 individual components on the circadian rhythm of HaCaT, an immortalized human keratinocyte line. CC extract and its bioactive components epicatechin (EC) and linalool (LO) significantly enhanced the circadian amplitude without altering the period. Gene expression analysis revealed that CC extract, EC, and LO altered the mRNA and protein levels of clock genes in a time-dependent manner. During molecular docking simulations, both EC and LO exhibited strong binding affinities for RORA, a key nuclear receptor involved in circadian regulation. Enhanced BMAL1 promoter activity following EC and LO treatments corroborated these findings. Furthermore, EC and LO demonstrated significant antioxidant activities, as evidenced by reduced reactive oxygen species levels and increased expression of antioxidant enzymes. EC and LO also upregulated skin barrier-related and ceramide synthesis genes and modulated the expression of cellular longevity-promoting genes. In conclusion, CC extract, particularly the components EC and LO, modulated circadian rhythms, reduced oxidative stress, and enhanced skin barrier function in keratinocytes. These findings highlight the potential of CC extract and its components as novel dermatological treatments to improve skin health and combat aging.
Article
Full-text available
Chronotherapy, the science of administering treatments in synchrony with circadian rhythms, has emerged as a promising strategy to enhance therapeutic efficacy and minimize adverse effects. Circadian rhythms govern numerous physiological processes, including immune regulation, hormone secretion, and skin barrier function. In dermatology, the skin demonstrates marked circadian variation in parameters such as transepidermal water loss (TEWL), pH, temperature, and pruritus intensity. Recent studies have shown that timing the administration of topical or systemic therapies according to these rhythms can improve outcomes in conditions such as psoriasis and atopic dermatitis. This review highlights the current understanding of circadian biology in skin physiology, the clinical relevance of chronotherapy in dermatologic diseases, and future directions for integrating chronobiology into dermatologic practice.
Article
Chronotherapy is the application of drugs and treatment methods at a specific time of day, increasing the effectiveness of drugs and reducing their side effects. The aim of chronotherapy is to optimize medical treatments by taking into account the body's circadian rhythms. Circadian rhythms are the physical, mental and behavioral changes that an organism experiences during a 24-hour cycle. The concept of chronotherapy came to the forefront about half a century ago. Until recently, it seemed to focus on improving the success of oncological treatments. Now, chronotherapeutic approaches are increasingly being used in the treatment of many diseases, including rheumatic, allergic and dermatological diseases. Dermatological chronotherapy has also gained importance since it was discovered that the permeability of the skin, which is the primary determinant of the bioavailability of topically applied drugs, is subject to daily fluctuations. Researchers are reporting that it is time to recommend topical drugs and skin care products at the most appropriate times of day. This chapter provides a concise and informative overview of chronotherapy, focusing particularly on its applications in the context of skin diseases based on current data.
Article
Full-text available
Ultraviolet B narrow band (UVB-NB) phototherapy is the gold standard treatment for vitiligo, primarily due to its immunomodulatory effects. Additionally, it may influence circadian melatonin balance, that may indirectly induce sleep regulation, which in turn could potentially contribute to vitiligo improvement. The association between melatonin, vitiligo and phototherapy has been little investigated. The aim of this study was to evaluate the current evidence regarding the effects of circadian melatonin regulation and sleep, particularly during vitiligo treatment with phototherapy. We undertook a narrative review to synthetize the evidence on this association through the MEDLINE/PubMed database, using combined search terms: melatonin, vitiligo, phototherapy, and circadian rhythm (sleep). A total of 56 articles were included. There are few studies on this relationship, and conflicting findings. Some studies have suggested that UV exposure and phototherapy might benefit vitiligo by stimulating melanocytes, which have melatonin receptors, and this could potentially synchronize the circadian regulation of melatonin. This improved melatonin balance could result in better sleep quality further enhancing the antiinflammatory properties of melatonin and contributing to vitiligo improvement. Less is known about the possible effects of the use of topical melatonin, with or without phototherapy, to treat vitiligo lesions. In conclusion, there is some evidence that circadian melatonin regulation plays an important role in the course of vitiligo, both through sleep regulation and its anti-inflammatory properties. The evidence suggests that the systemic and physiological properties of melatonin, especially its circadian behavior regulated by phototherapy, may be more effective in respect of vitiligo improvement than the use of topical melatonin. However, the effects of the oral intake of melatonin are less clear. Phototherapy, as a potential modulator of circadian melatonin rhythm, that influences sleep and clinical improvement of vitiligo, needs further examination, as does the use of melatonin as an adjuvant treatment to UVB phototherapy in vitiligo.
Article
Full-text available
Background: The skin plays different functions during the day and night to adapt to the changing environments. Various specialized creams are available to meet these skincare needs. The present study was conducted to explore the perspective of Indian dermatologists and cosmetologists on skin’s circadian rhythm and assess the effectiveness of a particular day and night cream formulation. Methods: A non-interventional, questionnaire-based study was conducted as part of a survey series on multiple dermatology products across India. Every month, a product-specific survey link was released to these registered doctors, and each doctor could take up to 10 surveys for a maximum of two products. A total of 379 healthcare professionals (HCPs) took the survey on the day and night cream and reported experiences of 2085 patients regarding the use of these products. Results: The doctors believed that for majority of the patients (1997, 97%), required day and night cream to maintain their skin’s circadian rhythm. Most patients (1440, 70%) were compliant with day and night care cream regimens. Most patients (966, 47%) were highly satisfied with the use of day and night cream, with majority of the patients (1028, 49.4%) experiencing considerable reduction in dark spots and uneven skin tone. Most patients (971, 47%) felt that the application of day and night cream left their skin moisturized and rejuvenated. Conclusions: The use of day and night cream improved skin condition and hydration, addressing circadian rhythm imbalance. Indian HCPs understand the impact of skin circadian rhythm imbalance and promote a comprehensive skincare regimen to patients.
Article
Full-text available
Background/purpose: Sunburn and other health risks associated with excess sun exposure place huge economic burdens on societies, and create discomfort and disease within susceptible individuals. Oral supplements that reduce sunburn may be advantageous. This study evaluated the safety and efficacy of Bend Skincare Anti-Aging Formula to ameliorate sunburn induced with a solar simulator. Methods: Subjects (n= 28) with Fitzpatrick skin phototypes I, II or III took four capsules daily of the supplement providing 1400 mg of eicosapentaenoic acid (EPA)+ docosahexaenoic acid (DHA), 120 mg of gamma-linolenic acid (GLA), 5 mg of lutein, 2.5 mg of zeaxanthin, and 1000 IU of vitamin D3 for 8 weeks. Skin on each subject's back was exposed to a progressive sequence of timed ultraviolet (UV) radiation exposure doses at baseline, and after 4 and 8 weeks treatment to determine their minimal erythema dose (MED). Results were compared before and after treatment using three paired t-tests and subsequently three linear mixed models. Results: Treatment significantly improved tolerance to UV exposure as evidenced by increased MED at 4 and 8 weeks compared to baseline (p<0.001). This protection increased with prolonged use of Bend Skincare Anti-Aging Formula as demonstrated by progressively increased MED between baseline and 4 weeks, and again between 4 and 8 weeks (p<0.001). Nearly 86% of patients responded to treatment within 4 weeks and 100% of patients responded by the end of the study, resulting in a 39% mean increase in MED at 4 weeks, and an 84% mean increase in MED at 8 weeks compared to baseline. Treatment was well tolerated with no product associated adverse events (AE) and only a few mild and expected side effects. Conclusion: Bend Skincare Anti-Aging Formula safely and effectively provides significant skin photo-protection that increases with continued use. This article is protected by copyright. All rights reserved.
Article
Full-text available
The DNA base excision repair pathway is the main system involved in the removal of oxidative damage to DNA such as 8-Oxoguanine (8-oxoG) primarily via the 8-Oxoguanine DNA glycosylase (OGG1). Our goal was to investigate whether the repair of 8-oxoG DNA damage follow a circadian rhythm. In a group of 15 healthy volunteers, we found a daily variation of Ogg1 expression and activity with higher levels in the morning compared to the evening hours. Consistent with this, we also found lower levels of 8-oxoG in morning hours compared to those in the evening hours. Lymphocytes exposed to oxidative damage to DNA at 8:00 AM display lower accumulation of 8-oxoG than lymphocytes exposed at 8:00 PM. Furthermore, altered levels of Ogg1 expression were also observed in a group of shift workers experiencing a deregulation of circadian clock genes compared to a control group. Moreover, BMAL1 knockdown fibroblasts with a deregulated molecular clock showed an abolishment of circadian variation of Ogg1 expression and an increase of OGG1 activity. Our results suggest that the circadian modulation of 8-oxoG DNA damage repair, according to a variation of Ogg1 expression, could render humans less susceptible to accumulate 8-oxoG DNA damage in the morning hours.
Article
Full-text available
There are several reports suggesting that the pathophysiology of psoriasis may be associated with aberrant circadian rhythms. However, the mechanistic link between psoriasis and the circadian time keeping system "the circadian clock" remains unclear. This study determined whether core circadian gene Clock played a regulatory role in the development of psoriasis. For this purpose, we compared the development of psoriasis-like skin inflammation induced by TLR7 ligand imiquimod (IMQ) between wild-type mice and mice with a loss-of-function mutation of Clock. We also compared the development of IMQ-induced dermatitis between wild-type mice and mice with a loss-of-function mutation of Period2 (Per2), another key circadian gene that inhibits CLOCK activity. We found that Clock mutation ameliorated IMQ-induced dermatitis whereas Per2 mutation exaggerated IMQ-induced dermatitis when compared with wild-type mice associated with decreased or increased IL-23 receptor (IL-23R) expression in γ/δ(+) T cells, respectively. In addition, CLOCK directly bound to the promoter of IL-23R in γ/δ(+) T cells and IL-23R expression in the mouse skin was under circadian control. These findings suggest that Clock is a novel regulator of psoriasis-like skin inflammation in mice via direct modulation of IL-23R expression in γ/δ(+) T cells, establishing a mechanistic link between psoriasis and the circadian clock.Journal of Investigative Dermatology accepted article preview online, 20 August 2015. doi:10.1038/jid.2015.316.
Article
Full-text available
Mutations in sunlight-induced melanoma arise from cyclobutane pyrimidine dimers (CPDs), DNA photoproducts that are typically created picoseconds after an ultraviolet (UV) photon is absorbed at thymine or cytosine. We found that in melanocytes, CPDs are generated for >3 hours after exposure to UVA, a major component of the radiation in sunlight and in tanning beds. These "dark CPDs" constitute the majority of CPDs and include the cytosine-containing CPDs that initiate UV-signature C→T mutations. Dark CPDs arise when UV-induced reactive oxygen and nitrogen species combine to excite an electron in fragments of the pigment melanin. This creates a quantum triplet state that has the energy of a UV photon but induces CPDs by energy transfer to DNA in a radiation-independent manner. Melanin may thus be carcinogenic as well as protective against cancer. These findings also validate the long-standing suggestion that chemically generated excited electronic states are relevant to mammalian biology. Copyright © 2015, American Association for the Advancement of Science.
Article
Full-text available
Mutations in sunlight-induced melanoma arise from cyclobutane pyrimidine dimers (CPDs), DNA photoproducts that are typically created picoseconds after an ultraviolet (UV) photon is absorbed at thymine or cytosine. We found that in melanocytes, CPDs are generated for >3 hours after exposure to UVA, a major component of the radiation in sunlight and in tanning beds. These “dark CPDs” constitute the majority of CPDs and include the cytosine-containing CPDs that initiate UV-signature C→T mutations. Dark CPDs arise when UV-induced reactive oxygen and nitrogen species combine to excite an electron in fragments of the pigment melanin. This creates a quantum triplet state that has the energy of a UV photon but induces CPDs by energy transfer to DNA in a radiation-independent manner. Melanin may thus be carcinogenic as well as protective against cancer. These findings also validate the long-standing suggestion that chemically generated excited electronic states are relevant to mammalian biology.
Article
Background: Melatonin is an endogenous hormone commonly associated with regulation of sleep. However, over the last two decades, research has elucidated a range of effects associated with the compound, including anti-inflammatory, both direct and indirect antioxidant activity, tissue regenerative benefits, and preservation of mitochondrial function. Melatonin's anti-inflammatory and antioxidant support, coupled with its mitochondrial support, make it an intriguing target for use to support skin health. Human skin and hair follicles express functional melatonin receptors. They also engage in substantial melatonin synthesis. By supporting cutaneous homeostasis, melatonin and its metabolites are thought to attenuate carcinogenesis and possibly other pathological processes, including hyperproliferative/inflammatory conditions. The primary extrinsic driver of aging has been considered to be exposure to ultraviolet (UV) light, which is well-established to contribute to sunburn, immunosuppression, skin aging, and carcinogenesis. Topically applied melatonin has been shown to reduce markers of reactive oxygen species formation and to reverse signs of skin aging. As the global population continues to age, photo-damage remains a significant cutaneous concern. While use of sunscreens and UV avoidance strategies are essential to mitigate skin cancer risks, the potential to protect the skin and improve the appearance of photo-damage through the use of topical antioxidant support is appealing. The evidence suggests that melatonin deserves consideration for topical use as an anti-aging and skin protective agent. It is shown to be both safe and effective when topically applied. J Drugs Dermatol. 2018;17(8):966-969.
Article
Melatonin is able to phase-shift the endogenous circadian clock and can induce acute temperature suppression. It is possible that there is a direct relationship between these phenomena. In a double-blind, placebo-controlled crossover study, 6 healthy volunteers maintained a regular sleep/wake cycle in a normal environment. From dusk until 24:00 h on days (D) 1–4 subjects remained in dim artificial lighting (<50 lux) and darkness (<1 lux) from 24:00–08:00 h. At 17:00 h on D3 either melatonin (0.05 mg, 0.5 mg or 5 mg) or placebo was administered. Melatonin treatment induced acute, dose-dependent temperature suppression and decrements in alertness and performance efficiency. On the night of D3, earlier sleep onset, offset and better sleep quality were associated with increasing doses of melatonin. The following day, a significant dose-dependent phase-advance in the plasma melatonin onset time and temperature nadir (D4-5) was observed with a trend for the alertness rhythm to phase-advance. A significant dose-response relationship existed between the dose of oral melatonin, the magnitude of temperature suppression and the degree of advance phase shift in the endogenous melatonin and temperature rhythms, suggesting that acute changes in body temperature by melatonin may be a primary event in phase-shifting mechanisms.
Article
Background: Ultraviolet radiation (UVR) by sunlight results in an increasing number of skin conditions. Earlier studies have suggested a protective effect of topical treatment with the pineal hormone melatonin. However, this protective effect has never been evaluated in natural sunlight, and the optimal dosing has not been clarified. Objective: The aim of this study was to investigate the sun protective effect of topical treatment with three different doses of melatonin (0.5%, 2.5%, 12.5%) against erythema induced by natural sunlight. Method: The study was a randomized, placebo-controlled, double-blind study in healthy volunteers. Twenty-three healthy volunteers, 8 male and 15 female, were enrolled. The protective effect of three different doses of melatonin cream (0.5%, 2.5%, 12.5%) against erythema induced by natural sunlight was tested. All participants had their backs exposed to sun from 1:22 PM to 2:02 PM local time and UV-index was 9. Primary outcome was reduction in erythema evaluated by chromatography after sun exposure, when treated with topical melatonin cream (0.5%, 2.5%, 12.5%) versus placebo and no treatment. The erythema reaction was evaluated with chromatography and visual scoring at baseline, one, four, eight and 24h after exposure. Results: Significant difference in erythema formation was found between areas treated with melatonin cream 12.5% and areas receiving placebo or no treatment (repeated measures ANOVA p=0.001). No differences were found between placebo and the 0.5% and 2.5% concentrations. Conclusion: Application of melatonin cream 12.5% protects against natural sunlight induced erythema.
Article
Elimination of reactive oxygen species (ROS) can be an important strategy to improve healing of wounds. ROS have an effect on proliferation and cell survival signaling, which results in alteration of apoptotic pathways in cells. Melatonin has antioxidant properties on skin wounds. In our study, we investigated the effects of topical melatonin (3%, w/w) on apoptosis and p53 protein expression together with parameters of oxidative stress in a cutaneous excision wound model. Bcl-2 protein levels in wound tissue at the end of days 3, 7, and 14 were significantly increased, while caspase-3 activity and p53 protein expression in wound tissue at the end of days 3, 7, and 14 were also reduced with melatonin treatment during wound healing. On days 3 and 7 after the wound, malondialdehyde level was reduced and glutathione was increased with melatonin treatment. Melatonin decreased myeloperoxidase levels and increased hydroxyproline levels in wound tissue at the end of day 7. However, melatonin had no significant effect on percentage of wound closure. Considering our results, topical melatonin displays antioxidant, antiapoptotic, and p53-inhibitory effects, but these effects are not sufficient for the acceleration of wound closure.